Diagnosticos da America S.A.(BR:DASA3)
R$3.51+0.16 (+4.78%)
BR:DASA3
Diagnosticos da America S.A. financials statements
R$3.51
At close:+0.16 (+4.78%)
Diagnosticos da America S.A. (DASA3) Ratios
Diagnosticos da America S.A. Ratios
BR:DASA3's free cash flow for Q3 2026 was R$238.14M. For the 2026 fiscal year, BR:DASA3's free cash flow was decreased by R$-129.68M and operating cash flow was R$367.82M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.24 | 1.55 | 1.25 | 1.25 | 0.99 |
| Quick Ratio | 1.20 | 1.46 | 1.17 | 1.18 | 0.94 |
| Cash Ratio | 0.58 | 0.33 | 0.28 | 0.21 | 0.16 |
| Solvency Ratio | -0.00 | 0.01 | 0.01 | 0.04 | 0.04 |
| Operating Cash Flow Ratio | -0.01 | 0.01 | -0.17 | -0.00 | 0.19 |
| Short-Term Operating Cash Flow Coverage | -0.02 | 0.03 | -0.63 | -0.02 | 0.62 |
| Net Current Asset Value | R$ -6.01B | R$ -10.32B | R$ -11.85B | R$ -12.03B | R$ -8.83B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.48 | 0.49 | 0.51 | 0.52 | 0.42 |
| Debt-to-Equity Ratio | 1.29 | 1.64 | 1.81 | 1.96 | 1.29 |
| Debt-to-Capital Ratio | 0.56 | 0.62 | 0.64 | 0.66 | 0.56 |
| Long-Term Debt-to-Capital Ratio | 0.46 | 0.54 | 0.55 | 0.59 | 0.42 |
| Financial Leverage Ratio | 2.70 | 3.34 | 3.58 | 3.79 | 3.08 |
| Debt Service Coverage Ratio | 0.43 | 0.73 | 0.61 | 0.83 | 0.45 |
| Interest Coverage Ratio | 0.62 | 0.54 | 0.48 | 0.58 | 0.14 |
| Debt to Market Cap | 1.34 | 4.38 | 1.55 | 1.54 | 0.41 |
| Interest Debt Per Share | 8.35 | 11.88 | 20.35 | 28.02 | 18.52 |
| Net Debt to EBITDA | 3.03 | 5.23 | 5.30 | 5.71 | 7.99 |
| Profitability Margins | |||||
| Gross Profit Margin | 30.38% | 27.37% | 27.27% | 28.93% | 29.92% |
| EBIT Margin | 8.19% | 5.12% | 6.40% | 8.37% | 1.43% |
| EBITDA Margin | 18.25% | 14.04% | 15.49% | 16.84% | 10.35% |
| Operating Profit Margin | 9.06% | 6.57% | 6.40% | 7.74% | 0.85% |
| Pretax Profit Margin | -5.49% | -6.97% | -6.99% | -4.41% | -3.59% |
| Net Profit Margin | -10.31% | -7.83% | -8.18% | -2.95% | -2.17% |
| Continuous Operations Profit Margin | -10.16% | -7.81% | -7.93% | -2.95% | -2.08% |
| Net Income Per EBT | 188.00% | 112.33% | 117.08% | 66.85% | 60.54% |
| EBT Per EBIT | -60.53% | -106.04% | -109.24% | -56.93% | -422.78% |
| Return on Assets (ROA) | -6.21% | -4.53% | -4.45% | -1.44% | -0.97% |
| Return on Equity (ROE) | -16.78% | -15.13% | -15.91% | -5.47% | -3.00% |
| Return on Capital Employed (ROCE) | 7.23% | 4.76% | 4.43% | 4.92% | 0.54% |
| Return on Invested Capital (ROIC) | 6.19% | 4.49% | 4.06% | 2.99% | 0.27% |
| Return on Tangible Assets | -8.13% | -7.32% | -7.53% | -2.41% | -1.62% |
| Earnings Yield | -20.22% | -50.50% | -17.02% | -5.18% | -1.20% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.99 | 3.09 | 3.58 | 3.21 | 4.26 |
| Payables Turnover | 8.98 | 7.74 | 6.74 | 6.02 | 5.93 |
| Inventory Turnover | 40.85 | 23.91 | 22.98 | 19.60 | 19.89 |
| Fixed Asset Turnover | 4.19 | 2.47 | 2.20 | 2.03 | 1.81 |
| Asset Turnover | 0.60 | 0.58 | 0.54 | 0.49 | 0.45 |
| Working Capital Turnover Ratio | 5.59 | 7.14 | 9.67 | 17.81 | 18.68 |
| Cash Conversion Cycle | 59.73 | 86.03 | 63.56 | 71.83 | 42.46 |
| Days of Sales Outstanding | 91.45 | 117.94 | 101.84 | 113.83 | 85.63 |
| Days of Inventory Outstanding | 8.93 | 15.27 | 15.88 | 18.62 | 18.35 |
| Days of Payables Outstanding | 40.66 | 47.17 | 54.17 | 60.62 | 61.53 |
| Operating Cycle | 100.38 | 133.21 | 117.72 | 132.45 | 103.98 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.03 | 0.02 | -1.29 | -0.05 | 2.32 |
| Free Cash Flow Per Share | -0.26 | -0.41 | -2.38 | -2.09 | 0.70 |
| Dividend Paid and CapEx Coverage Ratio | -0.12 | 0.05 | -1.19 | -0.02 | 1.15 |
| Capital Expenditure Coverage Ratio | -0.13 | 0.05 | -1.19 | -0.03 | 1.43 |
| Operating Cash Flow Coverage Ratio | -0.00 | 0.00 | -0.07 | -0.00 | 0.13 |
| Operating Cash Flow to Sales Ratio | -0.00 | 0.00 | -0.07 | -0.00 | 0.12 |
| Free Cash Flow Yield | -5.73% | -21.51% | -25.91% | -15.60% | 2.08% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.93 | -1.98 | -5.88 | -19.30 | -83.46 |
| Price-to-Sales (P/S) Ratio | 0.51 | 0.15 | 0.48 | 0.57 | 1.81 |
| Price-to-Book (P/B) Ratio | 0.83 | 0.30 | 0.93 | 1.06 | 2.51 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -17.44 | -4.65 | -3.86 | -6.41 | 48.19 |
| Price-to-Operating Cash Flow Ratio | -156.75 | 84.95 | -7.11 | -257.54 | 14.57 |
| Price-to-Earnings Growth (PEG) Ratio | 1.18 | 0.05 | -0.05 | -0.27 | -2.87 |
| Enterprise Value Multiple | 5.82 | 6.33 | 8.41 | 9.09 | 25.52 |
| Enterprise Value | 11.87B | 13.62B | 18.56B | 20.09B | 27.53B |
| EV to EBITDA | 5.82 | 6.33 | 8.41 | 9.09 | 25.52 |
| EV to Sales | 1.06 | 0.89 | 1.30 | 1.53 | 2.64 |
| EV to Free Cash Flow | -36.35 | -26.69 | -10.46 | -17.24 | 70.17 |
| EV to Operating Cash Flow | -326.68 | 487.54 | -19.26 | -692.69 | 21.21 |
| Tangible Book Value Per Share | 2.00 | -1.72 | -4.55 | -6.59 | -3.00 |
| Shareholders’ Equity Per Share | 5.47 | 6.34 | 9.81 | 12.68 | 13.46 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.85 | -0.12 | -0.13 | 0.33 | 0.42 |
| Revenue Per Share | 8.90 | 12.26 | 19.08 | 23.52 | 18.59 |
| Net Income Per Share | -0.92 | -0.96 | -1.56 | -0.69 | -0.40 |
| Tax Burden | 1.88 | 1.12 | 1.17 | 0.67 | 0.61 |
| Interest Burden | -0.67 | -1.36 | -1.09 | -0.53 | -2.51 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.21 | 0.21 | 0.20 | 0.08 | 0.10 |
| Stock-Based Compensation to Revenue | 0.00 | -0.00 | 0.00 | 0.00 | 0.07 |
| Income Quality | 0.06 | -0.03 | 0.85 | 0.07 | -5.98 |
Currency in BRL

